London-based real-estate lending firm LabTech Investments Group has announced the appointment of its new Chief Executive Officer, Chen Moravsky.
Mr. Moravsky has over two decades of industry experience with extensive experience across the real estate sector. Before joining LabTech, he served as the Deputy Chief Executive and CFO of PPHE Hotel Group, where he was responsible for overseeing the operational and fiscal activities. He also led the firm’s business development team.
2020 Trading Cup Gets Off to a Flying StartGo to article >>
In the official statement, Mr. Moravsky commented: “Our aim at LabTech is to allow the largest number of people to collaborate effectively and share resources, including technology, infrastructure, cultural facilities, and ideas. We already have a very significant property base in London and, given our technology edge, this is just the beginning. I want to expand our presence in London and across the globe.”
After its establishment, LabTech has acquired many properties in London’s Camden area as well as a number of buildings in central London including Holborn’s iconic Sicilian Avenue. Apart from a co-working and co-living space, LabTech provides its clients with recreational services like food and entertainment space. The firm is expanding its reach by acquiring many technology businesses and has integrated offline and online commerce and real estate technologies.
“This is a really exciting opportunity for me. LabTech Investments is building urban communities, enabled by technology and powered by people. Technology enabled ecosystems that make us stand out from the crowd. The backing of over £2 billion of property assets means that we can be confident our buildings are as impressive as our technology,” Mr. Moravsky added.
Welcoming Chen Moravsky, LabTech’s owner said: “Chen’s financial, property and business development knowledge is second to none. He has the skills and ability to roll out LabTech across the globe and make it the world’s leading co-working, co-living and entertainment tech company.”